Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Primary Penile Cancer: The Role of Adjuvant Radiation Therapy in the Management of Extranodal Extension in Lymph Nodes.

Johnstone PAS, Boulware D, Djajadiningrat R, Ottenhof S, Necchi A, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Spiess PE.

Eur Urol Focus. 2018 Oct 13. pii: S2405-4569(18)30300-6. doi: 10.1016/j.euf.2018.10.007. [Epub ahead of print]

PMID:
30327282
2.

Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.

Reddy JP, Pettaway CA, Levy LB, Pagliaro LC, Tamboli P, Rao P, Jayaratna I, Hoffman KE.

BJU Int. 2017 Apr;119(4):591-597. doi: 10.1111/bju.13686. Epub 2016 Nov 8.

3.

Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis.

Fajkovic H, Cha EK, Jeldres C, Robinson BD, Rink M, Xylinas E, Chromecki TF, Breinl E, Svatek RS, Donner G, Tagawa ST, Tilki D, Bastian PJ, Karakiewicz PI, Volkmer BG, Novara G, Joual A, Faison T, Sonpavde G, Daneshmand S, Lotan Y, Scherr DS, Shariat SF.

Eur Urol. 2013 Nov;64(5):837-45. doi: 10.1016/j.eururo.2012.07.026. Epub 2012 Jul 20.

PMID:
22877503
4.

Management of the lymph nodes in penile cancer.

Heyns CF, Fleshner N, Sangar V, Schlenker B, Yuvaraja TB, van Poppel H.

Urology. 2010 Aug;76(2 Suppl 1):S43-57. doi: 10.1016/j.urology.2010.03.001. Review.

PMID:
20691885
5.

Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study.

Sharma P, Djajadiningrat R, Zargar-Shoshtari K, Catanzaro M, Zhu Y, Nicolai N, Horenblas S, Spiess PE.

Urol Oncol. 2015 Nov;33(11):496.e17-23. doi: 10.1016/j.urolonc.2015.05.008. Epub 2015 Jun 10.

PMID:
26072110
6.

Predicting pelvic lymph node metastases in penile cancer patients: a comparison of computed tomography, Cloquet's node, and disease burden of inguinal lymph nodes.

Zhu Y, Zhang SL, Ye DW, Yao XD, Jiang ZX, Zhou XY.

Onkologie. 2008 Feb;31(1-2):37-41. doi: 10.1159/0000112462. Epub 2008 Jan 22.

PMID:
18268397
7.

Contemporary management of regional nodes in penile cancer-improvement of survival?

Djajadiningrat RS, Graafland NM, van Werkhoven E, Meinhardt W, Bex A, van der Poel HG, van Boven HH, Valdés Olmos RA, Horenblas S.

J Urol. 2014 Jan;191(1):68-73. doi: 10.1016/j.juro.2013.07.088. Epub 2013 Aug 2.

PMID:
23917166
8.

Adjuvant pelvic radiation is associated with improved survival and decreased disease recurrence in pelvic node-positive penile cancer after lymph node dissection: A multi-institutional study.

Tang DH, Djajadiningrat R, Diorio G, Chipollini J, Ma Z, Schaible BJ, Catanzaro M, Ye D, Zhu Y, Nicolai N, Horenblas S, Johnstone PAS, Spiess PE.

Urol Oncol. 2017 Oct;35(10):605.e17-605.e23. doi: 10.1016/j.urolonc.2017.06.001. Epub 2017 Jun 27.

PMID:
28666722
9.

Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.

Passoni NM, Fajkovic H, Xylinas E, Kluth L, Seitz C, Robinson BD, RouprĂȘt M, Chun FK, Lotan Y, Roehrborn CG, Crivelli JJ, Karakiewicz PI, Scherr DS, Rink M, Graefen M, Schramek P, Briganti A, Montorsi F, Tewari A, Shariat SF.

BJU Int. 2014 Oct;114(4):503-10. doi: 10.1111/bju.12342. Epub 2014 Apr 3.

10.

Prognostic significance of the degree of extranodal extension in patients with penile carcinoma.

Wang JY, Zhu Y, Tang SX, Zhang HL, Qin XJ, Zhang SL, Dai B, Ye DW.

Asian J Androl. 2014 May-Jun;16(3):437-41. doi: 10.4103/1008-682X.122862.

11.

Squamous cell carcinoma of the penis. III. Treatment of regional lymph nodes.

Horenblas S, van Tinteren H, Delemarre JF, Moonen LM, Lustig V, van Waardenburg EW.

J Urol. 1993 Mar;149(3):492-7.

PMID:
8437253
12.

Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.

Bruins HM, Dorin RP, Rubino B, Miranda G, Cai J, Daneshmand S, Skinner EC.

Eur Urol. 2012 Oct;62(4):671-6. doi: 10.1016/j.eururo.2012.04.050. Epub 2012 May 4.

PMID:
22575915
13.

The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience.

Lughezzani G, Catanzaro M, Torelli T, Piva L, Biasoni D, Stagni S, Crestani A, Guttilla A, Raggi D, Giannatempo P, Necchi A, Pizzocaro G, Colecchia M, Salvioni R, Nicolai N.

J Urol. 2014 Apr;191(4):977-82. doi: 10.1016/j.juro.2013.10.140. Epub 2013 Nov 18.

PMID:
24262497
14.

Establishing Criteria for Bilateral Pelvic Lymph Node Dissection in the Management of Penile Cancer: Lessons Learned from an International Multicenter Collaboration.

Zargar-Shoshtari K, Djajadiningrat R, Sharma P, Catanzaro M, Zhu Y, Nicolai N, Horenblas S, Spiess PE.

J Urol. 2015 Sep;194(3):696-701. doi: 10.1016/j.juro.2015.03.090. Epub 2015 Mar 20.

PMID:
25801766
15.

The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection.

Liu JY, Li YH, Zhang ZL, Yao K, Ye YL, Xie D, Han H, Liu ZW, Qin ZK, Zhou FJ.

World J Urol. 2013 Dec;31(6):1519-24. doi: 10.1007/s00345-013-1024-4. Epub 2013 Feb 28.

PMID:
23455885
16.

Prophylactic pelvic lymph node dissection in patients with penile cancer.

Djajadiningrat RS, van Werkhoven E, Horenblas S.

J Urol. 2015 Jun;193(6):1976-80. doi: 10.1016/j.juro.2014.12.019. Epub 2014 Dec 10.

PMID:
25498573
17.

Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma.

Graafland NM, van Boven HH, van Werkhoven E, Moonen LM, Horenblas S.

J Urol. 2010 Oct;184(4):1347-53. doi: 10.1016/j.juro.2010.06.016. Epub 2010 Aug 17.

PMID:
20723934
18.

Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan.

Chen MF, Chen WC, Wu CT, Chuang CK, Ng KF, Chang JT.

World J Urol. 2004 Apr;22(1):60-6. Epub 2003 Dec 5.

PMID:
14657999
19.

Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx.

Ai QY, King AD, Poon DMC, Mo FKF, Hui EP, Tong M, Ahuja AT, Ma BBY, Chan ATC.

Oral Oncol. 2019 Jan;88:124-130. doi: 10.1016/j.oraloncology.2018.11.007. Epub 2018 Nov 24.

PMID:
30616782
20.

Multi-center retrospective study of the prognosis and treatment outcomes of Japanese oral squamous cell carcinoma patients with single lymph node metastasis and extra nodal extension.

Hasegawa T, Yanamoto S, Otsuru M, Kakei Y, Okura M, Yamakawa N, Yamada SI, Ota Y, Umeda M, Kirita T, Kurita H, Ueda M, Komori T; Japan Oral Oncology Group (JOOG).

J Surg Oncol. 2018 Jun;117(8):1736-1743. doi: 10.1002/jso.25083. Epub 2018 May 1.

PMID:
29714825

Supplemental Content

Support Center